- Forums
- ASX - By Stock
- EMD
- Ann: Emyria receives ethics approval for EMD-RX5 Phase 3 trial
Ann: Emyria receives ethics approval for EMD-RX5 Phase 3 trial, page-9
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
|
|||||
Last
3.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.31M |
Open | High | Low | Value | Volume |
3.4¢ | 3.5¢ | 3.4¢ | $1.193K | 34.99K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31600 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 70000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31600 | 0.035 |
2 | 502250 | 0.034 |
4 | 39378 | 0.033 |
3 | 201280 | 0.032 |
1 | 32258 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.037 | 70000 | 1 |
0.038 | 37166 | 1 |
0.039 | 190000 | 2 |
0.040 | 57647 | 1 |
0.041 | 38238 | 2 |
Last trade - 11.49am 16/08/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online